Understanding Hyperlactatemia in Sepsis: Are We There Yet?
- PMID: 31206309
- PMCID: PMC6794111
- DOI: 10.1164/rccm.201905-0962LE
Understanding Hyperlactatemia in Sepsis: Are We There Yet?
Comment in
-
Reply to Nalos and Robergs and to De Backer and Vincent.Am J Respir Crit Care Med. 2019 Oct 15;200(8):1071-1072. doi: 10.1164/rccm.201905-1090LE. Am J Respir Crit Care Med. 2019. PMID: 31206300 Free PMC article. No abstract available.
Comment on
-
Understanding Lactatemia in Human Sepsis. Potential Impact for Early Management.Am J Respir Crit Care Med. 2019 Sep 1;200(5):582-589. doi: 10.1164/rccm.201812-2342OC. Am J Respir Crit Care Med. 2019. PMID: 30985210 Clinical Trial.
References
-
- Nalos M, McLean AS, Tang B.Myths and facts regarding lactate in sepsis Vincent J-L.editor. Annual update in intensive care and emergency medicine. Berlin, Germany: Springer; 201669–78.
-
- Gattinoni L, Vasques F, Camporota L, Meessen J, Romitti F, Pasticci I, et al. Understanding lactatemia in human sepsis: potential impact for early management. Am J Respir Crit Care Med. 2019;200:582–589. - PubMed
-
- Hernández G, Ospina-Tascón GA, Damiani LP, Estenssoro E, Dubin A, Hurtado J, et al. The ANDROMEDA SHOCK Investigators and the Latin America Intensive Care Network (LIVEN) Effect of a resuscitation strategy targeting peripheral perfusion status vs serum lactate levels on 28-day mortality among patients with septic shock: the ANDROMEDA-SHOCK randomized clinical trial. JAMA. 2019;321:654–664. - PMC - PubMed
-
- Levy B, Desebbe O, Montemont C, Gibot S. Increased aerobic glycolysis through beta2 stimulation is a common mechanism involved in lactate formation during shock states. Shock. 2008;30:417–421. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
